🚨 THE IVERMECTIN DOSING MANY CANCER PATIENTS ARE NOW DISCUSSING
A growing number of patients are referencing dosing frameworks shared by William Makis for off-label ivermectin use in cancer discussions.
What’s commonly cited:
✅ ~1 mg/kg/day as a typical starting point in these protocols
✅ Higher ranges discussed for more aggressive cancers
✅ Lower doses sometimes used initially and adjusted upward
✅ Long-term use claims based largely on anecdotal / case-based reports
Why this protocol gets attention:
👉 Supporters argue ivermectin may have dose-dependent anti-cancer effects
👉 Multiple preclinical studies suggest anti-tumor activity across several cancer types (MDPI)
👉 Clinical trials are beginning to explore ivermectin in oncology combinations, but evidence remains early-stage (ClinicalTrials)
Important context:
⚠️ There is no established evidence-based standard ivermectin dose for cancer treatment
⚠️ High-dose regimens discussed online are experimental and not validated in large randomized trials (Dr. Oracle)
Still, one thing is clear:
Patients are no longer waiting for the conversation to happen.
#Ivermectin #Fenbendazole #CancerCure #CancerTreatment #PharmacyinUSA
